Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role
Steven Quay, a biopharmaceutical executive with no background in infectious diseases, is no longer being considered for ...
The AHA is once again suing the Trump administration over its plan to revamp a federal drug discount program into one that ...
The gifts and payments that doctors receive from drugmakers increased inappropriate prescribing, likely leading to rising ...
The federal government has released new quality ratings for Medicare Advantage insurers for 2027, with Humana emerging as the ...
The Trump administration wants to make three big changes to the U.S. Census, including eliminating questions about race, ...
The FDA flagged a potential safety signal after four patient deaths in a trial testing a schizophrenia drug, Argenx faces an unusual setback, and more pharma news.
In 2030, U.S. mortality and morbidity rates will suddenly jump. This will happen not because there is a new pandemic or a ...
With research on abortion access barriers, STAT Wunderkind Betsy Pleasants is defining a framework for using AI tools without ...
As the midterm elections draw near, the MAHA movement is nearly invisible on the campaign trail and struggling to find a ...
Basic studies led to clinical and translational advances that no one could have predicted,” Robert Gallo writes of his work ...
The Trump administration announced Thursday that it is investigating nine universities for alleged fraud related to visas ...
A new proposal in Congress to scrap a surprise billing ban’s controversial arbitration system will need to to survive an onslaught of attacks from provider groups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results